— Know what they know.
Not Investment Advice

ERAS NASDAQ

Erasca, Inc.
1W: +12.0% 1M: -46.4% 3M: -7.4% YTD: +223.4% 1Y: +807.0% 3Y: +308.8%
$11.24
-0.36 (-3.15%)
 
Weekly Expected Move ±28.7%
$4 $7 $10 $13 $16
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 33 · $3.5B mcap · 187M float · 3.56% daily turnover · Short 59% of daily vol

Cash Flow Trends

Operating Cash Flow
-$95M +12.8% ▲
Capital Expenditures
$128K +99.4% ▲
5Y CAGR: -68.1%
Free Cash Flow
-$96M +27.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$6M +123.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$123M-$243M-$125M-$162M-$125M
Depreciation & Amort.$829K$3M$4M$4M$3M
Stock-Based Comp.$8M$20M$26M$27M$25M
Change in Working Capital$8M$16M$813K$2M-$3M
Other Non-Cash Items$28M$101M-$7M$20M$4M
Operating Cash Flow-$80M-$103M-$101M-$109M-$95M
— Investing Activities —
Capital Expenditures-$19M-$17M-$2M-$60K-$128K
Acquisitions (Net)$8M$4M$0$0$0
Investment Purchases-$106M-$134M-$314M-$403M-$151M
Investment Sales$60M$80M$245M$269M$261M
Other Investing-$8M-$4M-$20M-$22M-$10M
Investing Cash Flow-$65M-$71M-$91M-$157M$100M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$3M$3M$0$2M$0
Financing Cash Flow$439M$98M$1M$241M$1M
Net Change in Cash$295M-$76M-$191M-$25M$6M
Cash End of Period$361M$285M$93M$68M$74M
Free Cash Flow-$98M-$120M-$103M-$132M-$96M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms